Neuroimaging features of FOXR2‐activated CNS neuroblastoma: A case series and systematic review
Journal of Neuroimaging · 2023-05 · 33 (3) · 359-367
DOI: 10.1111/jon.13095 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Journal of Neuroimaging, online erschienen am 20.02.2023. Verfasst von Kenichiro Shimazaki und 7 weiteren Autor:innen. Beteiligte Einrichtung: Division of Neuroradiology, Department of Radiology, University of Michigan, Ann Arbor, Michigan, USA. Hauptthemen laut MEDLINE: Central Nervous System, Neuroblastoma. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Background and Purpose CNS neuroblastoma, FOXR2‐activated (CNS NB‐FOXR2) is a newly recognized tumor type in the 2021 World Health Organization classification of central nervous system (CNS) tumors. We aimed to investigate the clinical and neuroimaging findings of CNS NB‐FOXR2 and systematically review previous publications and three new cases.
Methods
We searched PubMed, SCOPUS, and Embase databases for patients with pathologically proven CNS NB‐FOXR2 with sufficient information for preoperative CT and MRI findings. Two board‐certified radiologists reviewed the studies and imaging data.
Results
Thirty‐one patients from six previous publications and 3 patients from our hospital comprised the study population (median age, 4.2 [range: 1.4‐16] years; 19 girls). Clinically, CNS NB‐FOXR2 mainly affected children between 2 and 6 years (24/34, 67.6%). Nausea/vomiting and seizures were reported as the main presenting symptoms (100% in total). The tumors frequently showed hyperdensity compared to the cortex on nonenhanced CT (4/5, 80%) with calcification along the inner rim of the tumor (4/5, 80%). More than half of patients showed susceptibility artifacts indicating intratumoral hemorrhage and/or calcification (15/28, 53.6%) on T2*‐ and/or susceptibility‐weighted imaging. Elevated relative cerebral blood volume and flow and percentile signal recovery were observed in one case with dynamic susceptibility contrast MRI.
Conclusions
Characteristic imaging features including hyperdense attenuation of the solid components and calcification along the inner rim on CT and susceptibility‐weighted imaging may assist with preoperative diagnosis of CNS NB‐FOXR2 in pediatric patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Neuroradiology, Department of Radiology, University of Michigan, Ann Arbor, Michigan, USA.
- Division of Pediatric Hematology/Oncology, Department of Pediatrics, Ann Arbor, Michigan, USA.
ORCID-Profile: Ryo Kurokawa, Andrea Franson, Mariko Kurokawa, Akira Baba
Zitieren
APA
Shimazaki, K., Kurokawa, R., Franson, A., Kurokawa, M., Baba, A., Bou-Maroun, L., Kim, J., & Moritani, T. (2023). Neuroimaging features of FOXR2‐activated CNS neuroblastoma: A case series and systematic review. Journal of Neuroimaging, 33(3), 359-367. https://doi.org/10.1111/jon.13095
Vancouver
Shimazaki K, Kurokawa R, Franson A, Kurokawa M, Baba A, Bou-Maroun L, et al. Neuroimaging features of FOXR2‐activated CNS neuroblastoma: A case series and systematic review. Journal of Neuroimaging. 2023;33(3):359-367. doi:10.1111/jon.13095
BibTeX
@article{Shimazaki2023,
author = {Shimazaki, Kenichiro and Kurokawa, Ryo and Franson, Andrea and Kurokawa, Mariko and Baba, Akira and Bou-Maroun, Laura and Kim, John and Moritani, Toshio},
title = {Neuroimaging features of FOXR2‐activated CNS neuroblastoma: A case series and systematic review},
journal = {Journal of Neuroimaging},
year = {2023},
volume = {33},
number = {3},
pages = {359--367},
doi = {10.1111/jon.13095}
}
EUVIMED